Relevance of cost-effectiveness analysis to clinicians and policy makers

JAMA. 2007 Jul 11;298(2):221-4. doi: 10.1001/jama.298.2.221.
No abstract available

MeSH terms

  • Biomedical Technology / economics*
  • Biomedical Technology / trends
  • Cost-Benefit Analysis
  • Decision Support Techniques
  • Models, Economic
  • Policy Making
  • Quality-Adjusted Life Years